Quintiles

Quintiles, Quest Diagnostics launch Q2 Solutions

Monday, July 6, 2015

Quintiles and Quest Diagnostics have launched Q2 Solutions, a new combined clinical trials laboratory services organization. Q2 Solutions brings together the clinical trials laboratory operations of the two parent organizations to provide biopharmaceutical customers with the diverse capabilities and end-to-end services required in the rapidly evolving biopharmaceutical industry. The launch of Q2Solutions is the result of the close of the previously announced global clinical trials laboratory services joint-venture transaction.

[Read More]

Quintiles launches new predictive and advanced analytics capabilities

Friday, June 19, 2015

Global CRO Quintiles has added advanced statistical monitoring and predictive analytics capabilities to its risk-based monitoring (RBM) solution. Predictive and Advanced Analytics combine Quintiles’ experience in RBM with its therapeutic and statistical sciences heritage to enable study teams to identify the right signals and predict clinical trial site performance and potential patient safety issues.

[Read More]

Quintiles launches Infosario One mobile app

Wednesday, June 17, 2015

Global CRO Quintiles is extending its Quintiles Infosario technology platform with mobile access to critical clinical trial information. Using the mobile app, key stakeholders in the drug development process can conveniently access site start-up, recruitment and compliance information as well as status updates on data queries and project milestones.

[Read More]

Society for Clinical Research Sites launches program for Asia-Pac Site Solutions Summit

Wednesday, June 17, 2015

The Society for Clinical Research Sites (SCRS), a global trade organization fully dedicated to representing the interests of clinical research sites, has announced a program for the 2015 Asia-Pac Site Solutions Summit. The Asia-Pac Site Solutions Summit will be July 30-31, 2015 in Melbourne, Australia. The Summit is open to clinical research investigators, site executives and industry stakeholders.

[Read More]

New Synexus board gears up for expansion through organic growth and acquisition

Wednesday, June 10, 2015

Following the completion of the management buyout of Synexus, the new board confirms its intention to expand the footprint of the company through organic growth and acquisition. Synexus, a multi-national company dedicated to the recruitment and running of clinical trials at its own research centers across the globe, intends to become a major player in the U.S., continue to expand its existing network of sites in Europe and Africa and develop a presence in Asia and South America.

[Read More]

Quintiles VP Dr. Judith Beach joins ACRES board of directors

Monday, May 18, 2015

The Alliance for Clinical Research Excellence and Safety (ACRES) has added Dr. Judith Beach, senior vice president and senior associate general counsel for regulatory affairs at Quintiles, to its board of directors. Beach brings her wide-ranging experience in legal and regulatory counsel on international and domestic regulatory issues in the pharmaceutical, medical device and biotechnology industries, as well as her chief privacy officer responsibilities, to ACRES mission of building a global system for accountable clinical research.

[Read More]